Back to Search
GERLINDE WERNIG, MD
MD
Anatomic Pathology Physician
NPI: 1609049741IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Pathology) Physician
Pathology — Hematology
Code: 207ZH0000X
A119554(CA)
Anatomic Pathology & Clinical Pathology Physician
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
A119554(CA)
Anatomic Pathology PhysicianPrimary
Pathology — Anatomic Pathology
Code: 207ZP0101X
A119554(CA)
Education
OTHER
Class of 1999
Research & Publications (10)
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.
PMID 18394554·Cancer Cell·2008
7-preclinical
The Jak2V617F oncogene associated with myeloproliferative diseases requires a functional FERM domain for transformation and for expression of the Myc and Pim proto-oncogenes.
PMID 18216297·Blood·2008
7-preclinical
Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model.
PMID 16478879·Blood·2006
7-preclinical
High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia.
PMID 18252861·Blood·2008
8-other
Role of JAK-STAT signaling in the pathogenesis of myeloproliferative disorders.
PMID 17124066·Hematology Am Soc Hematol Educ Program·2006
6-review
MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
PMID 16834459·PLoS Med·2006
7-preclinical
JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model.
PMID 16804112·Blood·2006
7-preclinical
Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation.
PMID 16365288·Proc Natl Acad Sci U S A·2005
7-preclinical
The vast majority of bone-marrow-derived cells integrated into mdx muscle fibers are silent despite long-term engraftment.
PMID 16085712·Proc Natl Acad Sci U S A·2005
7-preclinical
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
PMID 15837627·Cancer Cell·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 PASTEUR DR
PALO ALTO, CA 94304 - Phone
- (650) 723-7211
Quick Facts
- NPI
- 1609049741
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 27
- Publications
- 10
Are you this provider?
Claim Your Profile